Established in 2004, CIDP (Centre International de Développement Pharmaceutique) is an international Contract Research Organisation (CRO) that carries out high R&D activities for pharmaceutical, medical device, nutraceutical and cosmetic industries.
At CIDP, pioneering advancements in scientific research are deeply embedded in our ethos. With our multidisciplinary team, we’re committed to driving substantial contributions to scientific understanding.
Our recent research includes the development of an atlas to incorporate clinical variabilities of melasma spots in Brazilian skin. This comprehensive work was accomplished through the review of a set of standardized face photos of around 120 women with clinically diagnosed melasma with an aim of creating a visual reference for skin phototypes III to V. This atlas serves as a practical tool for dermatologists, aiding in the assessment and grading of melasma and supporting standardized clinical scales.
Furthermore, our relentless pursuit of knowledge has led us to delve deeper into the exposome, with a particular emphasis on compromised skin conditions like psoriasis, utilizing the Controlled Pollution Exposure System (CPES) developed by CIDP.
Today, we celebrate another milestone: our research has been recognized by the International Federation of Societies of Cosmetic Chemists (IFSCC).
Stay tuned as we prepare to showcase our findings at the upcoming IFSCC Congress in Brazil.
Congratulations to all our teams!